Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

European Heart Journal

Topics

Medicine

Internal Medicine

Endocrinology

Endocrinology, Diabetes And Metabolism

Molecular Biology

Show all topics

DOI

10.1093/eurheartj/eht187

License

CC-BY-NC

Other Formats

PDF